TY - GEN
T1 - Drugs that Act on the Immune System
T2 - Immunosuppressive and Immunostimulatory Drugs
AU - Meaney, Calvin J.
N1 - Publisher Copyright:
© 2015 Elsevier B.V.
PY - 2015
Y1 - 2015
N2 - The Side Effects of Drugs Annuals is a series of volumes in which the adverse effects of drugs and adverse reactions to them are surveyed. The series supplements the contents of Meyler's Side Effects of Drugs: the International Encyclopedia of Adverse Drug Reactions and Interactions. This review of the July 2013 to December 2014 publications on immunosuppressive and immunostimulatory or immunoenhancing drugs covers belatacept, cyclophosphamide, cyclosporine, everolimus, fingolimod, glatiramer, leflunomide, mycophenolic acid (mycophenolate mofetil and enteric-coated mycophenolate sodium), sirolimus (rapamycin), tacrolimus, temsirolimus, thiopurines, voclosporin and the immunoenhancing drug levamisole. Special reviews of cyclosporine nephrotoxicity and everolimus adverse effects in breast cancer patients are presented. Pharmacogenetic and pharmacogenomic associations to adverse effects are presented for cyclophosphamide, cyclosporine, leflunomide, mycophenolic acid, sirolimus, tacrolimus, and thiopurines..
AB - The Side Effects of Drugs Annuals is a series of volumes in which the adverse effects of drugs and adverse reactions to them are surveyed. The series supplements the contents of Meyler's Side Effects of Drugs: the International Encyclopedia of Adverse Drug Reactions and Interactions. This review of the July 2013 to December 2014 publications on immunosuppressive and immunostimulatory or immunoenhancing drugs covers belatacept, cyclophosphamide, cyclosporine, everolimus, fingolimod, glatiramer, leflunomide, mycophenolic acid (mycophenolate mofetil and enteric-coated mycophenolate sodium), sirolimus (rapamycin), tacrolimus, temsirolimus, thiopurines, voclosporin and the immunoenhancing drug levamisole. Special reviews of cyclosporine nephrotoxicity and everolimus adverse effects in breast cancer patients are presented. Pharmacogenetic and pharmacogenomic associations to adverse effects are presented for cyclophosphamide, cyclosporine, leflunomide, mycophenolic acid, sirolimus, tacrolimus, and thiopurines..
KW - Belatacept
KW - Cyclosporine
KW - Everolimus
KW - Immunostimulatory drugs
KW - Immunosuppressive drugs
KW - Mycophenolic acid
KW - Sirolimus
KW - Tacrolimus
UR - https://www.scopus.com/pages/publications/84938632184
U2 - 10.1016/bs.seda.2015.06.015
DO - 10.1016/bs.seda.2015.06.015
M3 - Conference contribution
AN - SCOPUS:84938632184
SN - 9780444635259
T3 - Side Effects of Drugs Annual
SP - 471
EP - 490
BT - A worldwide yearly survey of new data in adverse drug reactions, 2015
A2 - Ray, Sidhartha D.
PB - Elsevier
ER -